Viewing Study NCT00220233


Ignite Creation Date: 2025-12-25 @ 2:51 AM
Ignite Modification Date: 2025-12-26 @ 1:32 AM
Study NCT ID: NCT00220233
Status: COMPLETED
Last Update Posted: 2018-12-24
First Post: 2005-09-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Olmesartan as an add-on to Amlodipine in Hypertension
Sponsor: Sankyo Pharma Gmbh
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module